| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |